Health Ministries Should Consider 3 Elements When Deciding To Invest In UAVs To Deliver Health Care

Devex: Opinion: Your guide to investing in UAVs for delivering health care
Yasmin Chandani, director of inSupply, and David Sarley, senior program officer at the Bill & Melinda Gates Foundation

“[Unmanned aerial vehicles (UAVs)], also known as drones, have become a hot topic in public health for their potential in delivering life-saving medicines, blood, or vaccines to people in remote areas. But … not enough [of the conversation] comes from the perspective of health ministry officials, who have to make hard choices with little information. … The three most important elements that affect the decision to invest are the priority health objectives — which determines the product and demand — geography, and the characteristics of the UAV itself. … The decision whether to purchase UAVs offers the opportunity for a strategic system redesign that can optimize service levels while considering costs. And of course, money is not the only concern of supply chains. Speed, availability, and broader health benefits matter too, especially when it comes to opportunities for saving lives. … Our aim is to ensure countries are in the driver’s seat for deciding when and how to invest in UAVs…” (2/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.